Simplex Trading
ROIV icon

Simplex Trading’s Roivant Sciences ROIV Stock Holding History

Simplex Trading’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Sell
56,400
-62,800
-53% -$1.61M ﹤0.01% 2046
2025
Q4 		$2.59M Sell
119,200
-143,900
-55% -$2.84M ﹤0.01% 1773
2025
Q3 		$3.98M Buy
263,100
+59,100
+29% +$732K ﹤0.01% 1679
2025
Q2 		$2.3M Buy
204,000
+92,100
+82% +$998K ﹤0.01% 1976
2025
Q1 		$1.13M Sell
111,900
-8,100
-7% -$87.6K ﹤0.01% 2590
2024
Q4 		$1.42M Buy
120,000
+1,700
+1% +$20.1K ﹤0.01% 2517
2024
Q3 		$1.36M Sell
118,300
-93,200
-44% -$1.06M ﹤0.01% 2617
2024
Q2 		$2.23M Buy
211,500
+151,200
+251% +$1.66M ﹤0.01% 2089
2024
Q1 		$635K Sell
60,300
-75,500
-56% -$814K ﹤0.01% 3605
2023
Q4 		$1.52M Sell
135,800
-15,500
-10% -$151K ﹤0.01% 2602
2023
Q3 		$1.77M Buy
151,300
+49,000
+48% +$554K ﹤0.01% 2174
2023
Q2 		$1.03M Buy
102,300
+26,900
+36% +$241K ﹤0.01% 2567
2023
Q1 		$556K Sell
75,400
-7,500
-9% -$61.8K ﹤0.01% 3151
2022
Q4 		$662K Buy
+82,900
New +$461K ﹤0.01% 2892

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's ROIV Position: Q1 2026 in Review

Simplex Trading reduced its Roivant Sciences (ROIV) stake by 39% in Q1 2026, selling an estimated $1.44M and leaving 88,035 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

Simplex Trading first reported a position in ROIV in Q1 2022 and has held it in 12 quarters since. The position peaked at $3.12M in Q4 2025. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Simplex Trading held 88,035 shares of Roivant Sciences worth $2.44M as of Q1 2026.
  • Simplex Trading sold 55,862 Roivant Sciences shares in Q1 2026, an estimated $1.44M.
  • Roivant Sciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #1667 holding.
  • Simplex Trading first reported a position in Roivant Sciences in Q1 2022 and has held it in 12 quarters since.
  • Simplex Trading's Roivant Sciences position peaked at $3.12M in Q4 2025.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.